Open AccessA Telemedicine Buprenorphine Clinic to Serve New York City: Initial Evaluation of the NYC Public Hospital System's Initiative to Expand Treatment Access During the COVID-19 Pandemic
Author(s) -
Babak Tofighi,
Jennifer McNeely,
Dalia Walzer,
Kush Fansiwala,
Adam Demner,
Chloe S Chaudhury,
Ipsita Subudhi,
Daniel Schatz,
Timothy Reed,
Noa Krawczyk
Publication year - 2021
Publication title -
journal of addiction medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 42
eISSN - 1935-3227
pISSN - 1932-0620
DOI - 10.1097/adm.0000000000000809
Subject(s) - medicine , buprenorphine , telemedicine , (+) naloxone , opioid use disorder , pandemic , public health , health care , population , emergency medicine , emergency department , medical emergency , family medicine , covid-19 , opioid , psychiatry , nursing , disease , environmental health , infectious disease (medical specialty) , receptor , economics , economic growth
The purpose of this study was to assess the feasibility and clinical impact of telemedicine-based opioid treatment with buprenorphine-naloxone following the Coronavirus disease 2019 pandemic.